NEW YORK (GenomeWeb News) – Eastern Biotech and Life Sciences, Dubai and BGI Health have partnered to make available to parts of the Middle East a non-invasive prenatal diagnostic test for detecting trisomy 21.

Eastern Biotech launched the test called Trigene on Thursday, and it and BGI Health are also making the next-generation sequencing-based test available in the United Arab Emirates and other countries that are part of the Cooperation Council for the Arab States of the Gulf, Eastern Biotech said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.